Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
acute migrane
archive
bain capital
bausch health
biotech
breast cancer
clinical trials
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
fda
generic drug
glaxosmithkline
impel neuropharma
life sciences
medical
medical device
medicine
migraine
multiple myeloma
national blog main
national organization for rare disorders
new york
new york blog main
new york top stories
nirogacestat
orbimed
ra capital
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
recalls
san francisco blog main
san francisco top stories
satsuma pharmaceuticals
shin nippon biomedical laboratories
springworks therapeutics
tpg biotech
What
drug
migraine
2
×
pfizer
2
×
activity
bacteria
based
biotech
brand
class
companies
company
days
dog
drugs
firm
hasn’t
ipo
ipos
leading
line
medication
microbiolog
pharmaceutical
place
popular
potential
potentially
prep
recalled
relpax
risk
satsuma
securing
slowed
spinout
springworks
stopped
summer
triptan
tryptamine
Language
unset
Current search:
migraine
×
pfizer
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@slashgear.com
4 years ago
Popular migraine drug recalled over potentially serious bacteria risk